Vanguard Group Inc Coherus Bio Sciences, Inc. Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 10,570,515 shares of CHRS stock, worth $14.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,570,515

Previous 11,151,905 5.21%

Holding current value

$14.5 Million

Previous $9.03 Million 14.58%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$0.72 - $1.12 $418,600 - $651,156	-581,390 Reduced 5.21%	10,570,515 $7.72 Million
Q1 2025 May 09, 2025	SELL	$0.81 - $1.66 $2,001 - $4,101	-2,471 Reduced 0.02%	11,151,905 $9.03 Million
Q4 2024 Feb 11, 2025	SELL	$0.67 - $1.71 $104,725 - $267,283	-156,306 Reduced 1.38%	11,154,376 $15.4 Million
Q3 2024 Nov 13, 2024	BUY	$0.99 - $1.8 $701,210 - $1.27 Million	708,293 Added 6.68%	11,310,682 $11.8 Million
Q2 2024 Aug 13, 2024	BUY	$1.58 - $2.51 $826,079 - $1.31 Million	522,835 Added 5.19%	10,602,389 $18.3 Million
Q1 2024 May 10, 2024	SELL	$2.02 - $3.14 $561,273 - $872,474	-277,858 Reduced 2.68%	10,079,554 $24.1 Million
Q4 2023 Feb 14, 2024	BUY	$1.59 - $3.85 $914,703 - $2.21 Million	575,285 Added 5.88%	10,357,412 $34.5 Million
Q3 2023 Nov 14, 2023	BUY	$3.74 - $5.45 $3.49 Million - $5.08 Million	932,476 Added 10.54%	9,782,127 $36.6 Million
Q2 2023 Aug 14, 2023	BUY	$3.79 - $8.3 $11.3 Million - $24.8 Million	2,992,451 Added 51.09%	8,849,651 $37.8 Million
Q1 2023 May 15, 2023	BUY	$5.89 - $10.52 $243,363 - $434,665	41,318 Added 0.71%	5,857,200 $40.1 Million
Q4 2022 Feb 10, 2023	BUY	$5.69 - $10.07 $3.34 Million - $5.91 Million	587,181 Added 11.23%	5,815,882 $46.1 Million
Q3 2022 Nov 14, 2022	BUY	$7.17 - $13.87 $2.48 Million - $4.79 Million	345,286 Added 7.07%	5,228,701 $50.2 Million
Q2 2022 Aug 12, 2022	BUY	$5.86 - $13.23 $857,400 - $1.94 Million	146,314 Added 3.09%	4,883,415 $35.4 Million
Q1 2022 May 13, 2022	BUY	$10.92 - $16.41 $2.07 Million - $3.11 Million	189,572 Added 4.17%	4,737,101 $61.2 Million
Q4 2021 Feb 14, 2022	BUY	$15.81 - $18.99 $525,334 - $630,999	33,228 Added 0.74%	4,547,529 $72.6 Million
Q3 2021 Nov 12, 2021	BUY	$12.68 - $17.79 $490,677 - $688,419	38,697 Added 0.86%	4,514,301 $72.5 Million
Q2 2021 Aug 13, 2021	BUY	$12.95 - $15.41 $58 Million - $69 Million	4,475,604 New	4,475,604 $61.9 Million

Others Institutions Holding CHRS

# of Institutions

119

Shares Held

58.2M

Call Options Held

89.3K

Put Options Held

31K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $106M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Coherus Bio Sciences, Inc. Transaction History